AUTOGENE CEVUMERAN
UNII L8HDH9IB06

Substance Identification & Data

This profile provides standardized clinical and technical data for Autogene Cevumeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L8HDH9IB06.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2365453-34-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

L8HDH9IB06

CAS Registry Number

2365453-34-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AUTOGENE CEVUMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175745

National Cancer Institute reference terminology for clinical and research data.

INN ID

11177

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-204

Identifier assigned by the United States Adopted Names Council.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Autogene Cevumeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AUTOGENE CEVUMERAN

Common Names & Synonyms

A 5'-CAPPED SINGLE-STRANDED MESSENGER RNA (MRNA) CONSTRUCT FOR THE EXPRESSION OF PATIENT-SPECIFIC TUMOUR NEOANTIGENS COMPRISING A 5'-CAP, A 5'-UNTRANSLATED REGION DERIVED FROM HUMAN ALPHA-GLOBIN MRNA, AN OPTIMISED KOZAK SEQUENCE, SEQUENCES ENCODING A SECRETORY SIGNAL PEPTIDE (SEC 2.0), TRANSMEMBRANE AND CYTOPLASMIC DOMAINS OF A MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS I MOLECULE (MITD), A 3'-UNTRANSLATED REGION (FI) AND A POLY(A)-TAIL; SEQUENCES ENCODING PATIENT SPECIFIC ANTIGENS ARE INSERTED BETWEEN THE SECRETORY SIGNAL PEPTIDE AND THE TRANSMEMBRANE/CYTOPLASMIC ENCODING DOMAINS

AUTOGENE CEVUMERAN [INN]

AUTOGENE CEVUMERAN [USAN]

AUTOGENE CEVUMERAN [WHO-DD]

RNA (RECOMBINANT 5'-(1,2-(M7GM-(5'->5')-P-(P(R))-SP-P-G))-CAPPED 5'-UTR (HUMAN .ALPHA.-GLOBIN RNA-KOZAK)/SECRETORY SIGNAL PEPTIDE SEC2.0-SPECIFYING/PATIENT-SPECIFIC TUMOR NEOANTIGEN-SPECIFYING INSERTION SITE/MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I TRANSMEMBRANE AND CYTOPLASMIC DOMAINS-SPECIFYING/3'-UTR (AES MRNA-MITOCHONDRIAL 12S RRNA)-CONTAINING POLY(A)-TAILED MESSENGER RO7198457 CONSTANT REGION), INNER SALT